Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Research from C.S. Ambrose and co-authors in the area of flu vaccines published
August 27th, 2008
Investigators publish new data in the report 'Duration of protection provided by live attenuated influenza vaccine in children.' "Reliable availability of influenza vaccine before October could enable the vaccination of many children who might not otherwise be vaccinated. Available data for children were analyzed to describe protection provided by live attenuated influenza vaccine (LAIV) for greater than 5 months postvaccination," scientists writing in the The Pediatric Infectious Disease Journal report. "Four studies conducted in children aged 6 months to 18 years were identified. Culture-confirmed efficacy against A/H1N1 and A/H3N2 strains at 9-12 months...
Source: Vaccine Weekly (2008-08-27)
|
